IFM Therapeutics
IFM Therapeutics' Leadership Team includes H. Martin Seidel and 10 others.
Dennis Dean
Chief Development Officer
Ed Olhava
SVP of Preclinical Development
H. Martin Seidel
CEO
Matthias Geyer
Scientific Founder
William R. Roush
EVP of Chemistry
View all
15 members
6 members